{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:33:58Z","timestamp":1791383638189,"version":"4.3.3"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["04X-3874"],"award-info":[{"award-number":["04X-3874"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"crossref"}]},{"name":"EU 7th Framework project REPLACES"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.nbd.2011.12.013","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T15:55:37Z","timestamp":1323705337000},"page":"939-953","source":"Crossref","is-referenced-by-count":273,"title":["Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of \u03b1-synuclein in midbrain dopamine neurons"],"prefix":"10.1016","volume":"45","author":[{"given":"M.","family":"Decressac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lundblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Weikop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bj\u00f6rklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2011.12.013_bb0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.12.013_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2008.02.014","article-title":"Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice","volume":"435","author":"Alerte","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.12.013_bb0015","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1523\/JNEUROSCI.6194-10.2011","article-title":"Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family","volume":"31","author":"Anwar","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.013_bb0020","first-page":"872","article-title":"Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease","volume":"18","author":"Azeredo da Silveira","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.12.013_bb0025","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1471-4159.2003.01742.x","article-title":"Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines","volume":"85","author":"Baptista","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.013_bb0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.013_bb0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","article-title":"Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease?","volume":"25","author":"Chu","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.013_bb0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/cne.20828","article-title":"Nurr1 in Parkinson's disease and related disorders","volume":"494","author":"Chu","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.013_bb0045","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.12.013_bb0210","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/brain\/awr149","article-title":"GDNF fails to exert neuroprotection in a rat a-synuclein model of Parkinson's disease","volume":"134","author":"Decressac","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.013_bb0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00401-010-0739-1","article-title":"Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies","volume":"120","author":"Dugger","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.12.013_bb0060","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1523\/JNEUROSCI.1122-04.2004","article-title":"Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system","volume":"24","author":"Georgievska","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.013_bb0065","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.0711053105","article-title":"The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease","volume":"105","author":"Gorbatyuk","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.nbd.2011.12.013_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1046-2023(02)00219-0","article-title":"Production methods for gene transfer vectors based on adeno-associated virus serotypes","volume":"28","author":"Grimm","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.nbd.2011.12.013_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pneurobio.2005.09.001","article-title":"The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease","volume":"77","author":"Jankovic","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2011.12.013_bb0080","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.013_bb0085","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/10430340252837206","article-title":"Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra","volume":"13","author":"Klein","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.013_bb0090","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","article-title":"Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity","volume":"15","author":"Kontopoulos","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.12.013_bb0095","doi-asserted-by":"crossref","first-page":"e17698","DOI":"10.1371\/journal.pone.0017698","article-title":"Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein","volume":"6","author":"Koprich","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2011.12.013_bb0100","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1523\/JNEUROSCI.3821-06.2006","article-title":"Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis","volume":"26","author":"Larsen","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.013_bb0105","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","article-title":"alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease","volume":"99","author":"Lo Bianco","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.nbd.2011.12.013_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0079-6123(10)84004-X","article-title":"Genetic mouse models of Parkinson's disease. The state of the art","volume":"184","author":"Magen","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.013_bb0115","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.nbd.2006.04.007","article-title":"Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression","volume":"23","author":"Maingay","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.013_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.12.013_bb0125","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.20753","article-title":"Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease","volume":"59","author":"Nishioka","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.013_bb9000","author":"Paxinos","year":"1986","journal-title":"The RAT Brain in Stereotaxic Coordinates"},{"key":"10.1016\/j.nbd.2011.12.013_bb0130","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.013_bb0135","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.12.013_bb9005","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/0024-3205(86)90395-4","article-title":"A rapid and sensitive assay foro tyrosine-3-monooxygenase based upon the release of 3H2O and adsorption of [3H]-tyrosine by charcoal","volume":"39","author":"Reinhard","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2011.12.013_bb0140","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuroscience.2009.03.002","article-title":"Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice","volume":"160","author":"Schell","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.013_bb0145","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","article-title":"Lewy bodies","volume":"103","author":"Shults","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.nbd.2011.12.013_bb0150","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.013_bb0155","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.12.013_bb0160","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.12.013_bb0165","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2006.04146.x","article-title":"Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells","volume":"99","author":"Tehranian","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.013_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0079-6123(10)84005-1","article-title":"Viral vector-mediated overexpression of alpha-synuclein as a progressive model of Parkinson's disease","volume":"184","author":"Ulusoy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.013_bb0175","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.013_bb0180","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/jnr.21310","article-title":"Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein","volume":"85","author":"Wakamatsu","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.12.013_bb0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0079-6123(00)27012-X","article-title":"Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement","volume":"127","author":"Winkler","year":"2000","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.013_bb0190","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease","volume":"91","author":"Yamada","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.013_bb0195","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2004.05.118","article-title":"Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells","volume":"367","author":"Yu","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.12.013_bb0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.013_bb0205","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111003883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111003883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T20:09:30Z","timestamp":1561061370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996111003883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0969996111003883"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.12.013","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}